BIOTRONIK’s Longstanding Cooperation with Die ARCHE: A Partnership for Children

A BIOTRONIK employee shares his experience as a patient with an implantable cardiac monitor.

Optimizing Patient Experience With eHealth Solutions

Exploring the Science Behind Love's Cardiovascular Benefits

A Donation Ceremony Took Place at the Woermannkehre, on January 18, 2024

In the midst of celebrating 60 years of service in partnership with the healthcare community, BIOTRONIK’s Electrophysiology business marked another important milestone of its own in 2023 – its 20 th anniversary.

2023 was a landmark year for BIOTRONIK – not simply in name or number – but in action. The company’s 60 th year of operations was a busy one for lifesaving innovations like the Amvia pacemaker and CRT-P family and Oscar catheter, to laying the groundwork for helping a whole new community of patients with the Prospera TM spinal cord stimulation system, a BIOTRONIK first.

Prof. Anders Wanhainen Highlights New ESVS Recommendations, Advising on Suspended Personal Radiation Protection Systems for the First Time

What began with one lifesaving mission between two students in early 1960s Berlin now spans the globe: BIOTRONIK is active in more than 100 countries.

New Research Confirms Effective Tools to Better Protect Patients with High Stroke Risk

This year is a special year for BIOTRONIK, one in which we mark sixty years of service in the healthcare community.

How One Colleague’s Act Inspires a Culture of Preparedness at BIOTRONIK

A global company that has been making devices for 60 years and has vast experience helping patients with heart and blood vessel diseases, BIOTRONIK has expanded to the chronic pain space with BIOTRONIK Neuro.

With being able to listen in while getting something else done – such as running, commuting or cooking – podcasts offer up great ways for us to keep up with what’s going on in every field imaginable – and cardiology is no exception.

The Findings of the MATRIX Study Could Change Clinical Practice, Says Cardiac Rhythm Expert Dr. Ignasi Anguera Camos

Our colleagues from around the world show that it sometimes doesn't take much to make a difference

Explore the Latest Research on AI in Medicine, Atrial Fibrillation Detection, Resorbable Scaffolds, Non-Contact Charge Density Mapping, and Spinal Cord Stimulation to Enhance Clinical Practice and Stay Ahead of the Curve

Pioneering spirit and passion for innovation – that's what BIOTRONIK stands for. This is also shown by the company’s flagship innovations: from the first German pacemaker to the GoldTip ablation catheter, a real innovation in electrophysiology that is still the gold standard today.

A contribution by David Hayes, MD, Chief Medical Officer at BIOTRONIK Inc.

Recent Studies Reveal Optimal Levels of Physical Activity for Cardiovascular Health

The first patient visit to BIOTRONIK in a long while met with excitement and enthusiasm

Women’s History Month is the perfect time to celebrate the incredible achievements of the women who have shaped the field of cardiology.

Biotronik’s Chief Procurement Officer Takes a Look at the New Statutory Regulations

With 2023 upon us, BIOTRONIK employees are no exception to the kind of motivated goal-setting we often see at this time of year. Whether it’s more sports, a more mindful approach to everyday life, or to quit smoking—it’s important to have as much support as possible. That’s why BIOTRONIK’s Health Program 2023 will work to empower employees to achieve their health-related goals. 2023’s edition places a special focus on improving mental health at work, alongside the company’s work to promote physical health.

While in office as US Vice-President, Dick Cheney had the remote monitoring function of his pacemaker turned off over concerns a malicious hacker could access his device. In 2012, an episode of the TV drama Homeland depicts a faraway terrorist hacking into the fictional US Vice-President’s pacemaker and assassinating him. It may have made for thrilling TV, but is successful malicious hacking of a cardiac device possible in real life?

Whether it’s from our engaged team at BIOTRONIK, inspiring patients, or expert physicians—one thing is clear from our most read BIOTRONIK blog stories of 2022: real stories, from real people, touch hearts.

2022 has been a surprising year at times when it comes to studies of what we eat and how it affects heart health. Although there have been numerous publications looking at this relationship this year—a few stood out to us, and they may have interesting implications for our diets.

Digital Health brings opportunities to advance patient care but also new challenges. In addition to a marked increase in data volume in the clinical space and increased patient involvement in care, digital technology’s role in the care space has changed. This also allows enormous opportunities for early detection and preventing clinical problems, particularly for patients with an implanted cardiac device—when data and new digital technologies are optimally managed.

How New Strategies Move Beyond Simple AF Detection to Focus on Reducing AF Burden and Monitoring Disease Progression

After starting enrollment in 2019, Dr. Valentina Kutyifa announced the first results of the BIOTRONIK-supported BIO-LIBRA trial at the Annual Heart Rhythm Society meeting (HRS 2022).

BIOTRONIK Employees Share Their Experiences as Relatives of Cardiac Patients

More than 1.7 million cardiac implantable electronic devices are implanted worldwide each year. Young implant wearers in particular have many questions about whether and how their life will change after the procedure. One of the most important ones: whether and to what extent they can practice sports again. Media coverage of the Danish professional soccer player Christian Eriksen, who had an ICD (implantable cardioverter-defibrillator) implanted after collapsing during an international match, has further increased interest in the interaction between cardiovascular diseases and sport.

Rolf Opuchlich has been with the BIOTRONIK Quality Team since 1997. In 2020, he received his own device. Despite knowing just about everything there is to know about the defibrillator he now wears, on his first vacation after getting his implant he was still a bit restless. “I was fairly nervous that first time,” says Rolf looking back at his first flight with his ICD after implantation. “Even though I know our devices well and had everything I needed with me.”

Continuing a company tradition that started a decade ago, BIOTRONIK employees at the company’s headquarters mounted their bicycles in early July to race through Berlin as a team during VeloCity Berlin—an event that sees teams come together for either a 60km race or a 90km race through the German capital.

Around 49 million people in the EU suffer from cardiovascular diseases. Here, Coronary Artery Disease (CAD) accounts for the major share of the diseases. In this context, narrowing of vessels by atherosclerotic processes is closely linked to an unhealthy lifestyle. This was also the case for the North Rhine-Westphalian deacon Rainer Beerhenke. After successful stent placement and a bypass surgery in 2021, the 58-year-old is again living life to the full and is one of the first patients to take part in the EU-funded TIMELY project, which aims to improve the range of therapies for CAD patients.

Cardiac catheterization labs can be complicated workplaces when it comes to occupational safety.

Higher quality of life, more biodiversity and a better climate – the advantages of green cities seem obvious. Green living – including breathing clean air – plays an especially crucial role for our heart health and overall well-being. On the occasion of World Environment Day, we looked at what effect air pollution has on heart health and what each of us can do to make our cities more livable.

Why Innovative Treatment Solutions Should Be Designed With the Nurse in Mind

The incidence of atrial fibrillation (AF) in patients with implantable cardioverter-defibrillators (ICDs) is approximately 21 percent (mean annual probability) 1 and is often undetected – and therefore untreated.

Cardiac pacemaker implantations are now routine interventions. Around three million people worldwide have a pacemaker, and every year 600,000 more receive an implant. Nevertheless, the diagnosis and procedure can look challenging for patients at first— especially patients who are athletes or enjoy being active.

More than ten years after BIOTRONIK received approval for its first ProMRI pacemaker, allowing the first cardiac device patients access to MRI scans, we still get many questions from patients about what documents they should bring to a scanning appointment—to ensure their radiologist doesn’t turn them away.

Cardiovascular research has achieved a lot in the last few decades—but even today the cardiology community is discussing whether the field needs gender-specific guidelines for treating cardiovascular diseases. One of the biggest obstacles is one of the most common problems in scientific research—a simple lack of data.

It’s hard to think of information that feels more personal than data about our own health. Yet we’re generating and monitoring more health data now than ever before. Whether it’s specific technology designed to help manage certain medical conditions—such as BIOTRONIK’s Patient App or remote care with Home Monitoring—or the plethora of more general, consumer-grade wearables and health apps, there are more and more digital options to help manage patient health.

An American survey last year found that health-related goals topped the priority list of New Year’s resolutions for 2021. Around half of those surveyed wanted to exercise more or lose weight, while about 40 percent wanted to improve their diets and 10 percent wanted to quit smoking. Of those people who make resolutions, many say they do, in fact, keep them. Around half of respondents in one such survey said they kept at least some of their 2020 resolutions. About 35 percent said they met all of their goals and just 16 percent say they didn’t keep any of their resolutions.

How a CLS Pacemaker Helps Cabaret Artist Wolfgang Koch Live Life to the Fullest

Read the Most Common Patient Questions We Received in 2021 and Answers From Our Experts

Atrial Fibrillation Is the Most Common Type of Heart Arrhythmia and Affects About 30 Million People Worldwide.

As More Data Comes In, There’s Plenty of Reasons to Be Optimistic About Scaffolds

As ICM Use Becomes More Common, How Can Clinics Manage the Workloads That Come With the Longer-Term Diagnostic Windows ICMs Offer?

Four of Our Most Inspiring Leaders Talk About the Most Important Lessons From Their Careers